Jai Health plans heart disease biomarker test launch; Leicester Uni gets £7M biomarker investment;

> Indian company Jai Health is planning a launch of its genetic biomarker-based test to assess the risk of heart disease. Article

> The University of Leicester (U.K.) has received a £7 million ($11 million) donation to build a new biomarker facility. Press release | Article

> Genetic variants behind melanoma could affect how patients respond to Plexxikon and Roche's ($RHHBY) Zelboraf (vemurafenib). Press release | Abstract

> Chromosomal aberrations could point the way to personalized care, according to a review from the University of Colorado Cancer Center. Abstract | Blog post

> Plasma osteopontin marks prostate cancer aggression, risk and treatment response. Abstract

> Urine podocin:nephrin mRNA ratio could be a useful marker in kidney disease. Abstract

> Antigen Discovery gets a Phase II SBIR grant to find biomarkers linked with protection against malaria. Press release

> Researchers find three more diabetes markers. Article

> Boston diagnostics company Immunetics has received $629,000 in equity for the commercialization of a blood platelet contamination tester for hospitals and blood banks. Article

> Norwegian biotech and biopharma company BerGenBio has appointed former KuDOS CEO Barrie Ward to its board. Press release

And Finally… Speech patterns can be used as a marker for both depression severity and response to treatment, according to a U.S. and Australian research project. Abstract | Press release